NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

獸醫腫瘤學的全球市場:規模,佔有率,預測,機會分析

Veterinary Oncology Market, by Animal Type, by Therapy Type, by Mode of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2026

出版商 Coherent Market Insights 商品編碼 914041
出版日期 內容資訊 英文 225 Pages
商品交期: 2-3個工作天內
價格
獸醫腫瘤學的全球市場:規模,佔有率,預測,機會分析 Veterinary Oncology Market, by Animal Type, by Therapy Type, by Mode of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2026
出版日期: 2019年08月26日內容資訊: 英文 225 Pages
簡介

本報告提供全球獸醫腫瘤學市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各動物的種類·治療類型·投藥法·用途·流通管道·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的及前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概要

  • 報告的說明
  • 摘要整理
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
  • 影響分析
  • 獸醫腫瘤學的預防·管理的配合措施
  • 放射線治療
  • 市場趨勢
  • 產品回收
  • 流行病學
  • 主要的開發
  • 貓的癌症
  • 狗的癌症
  • 獸醫學一般地所使用的化療劑
  • 法規方案
  • 獸醫學:專利資訊
  • 動物的癌症:提升意識宣傳活動
  • 合併·收購
  • PEST分析

第4章 市場分析:各動物類別

  • 簡介
  • 寵物
  • 家畜動物

第5章 市場分析:各治療類型

  • 簡介
  • 化療
  • 聯合治療
  • 免疫療法
  • 標靶治療

第6章 市場分析:各投藥法

  • 簡介
  • 口服
  • 靜脈內

第7章 市場分析:各用途

  • 簡介
  • 狗的淋巴瘤
  • 骨癌(OSA)
  • 肥胖細胞癌症
  • 黑色素瘤
  • 多發性骨髓瘤

第8章 市場分析:各流通管道

  • 簡介
  • 醫院藥局
  • 政府機關
  • 零售藥局

第9章 市場分析:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第10章 競爭情形

  • 企業簡介
    • Zoetis Inc.
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA
  • 分析師的見解

第11章 章節

  • 參照資料
  • 調查方法
  • 關於本公司
目錄

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines.

Market Dynamics

  • Increasing prevalence of veterinary cancer is expected to boost the global veterinary oncology market growth during the forecast period. For instance, according to the Veterinary Cancer Society, in 2016, cancer is the leading cause of death in 47% of dogs diagnosed with cancer over the age of 10 years; and 32% of cats, where Feline Leukaemia Virus (FeLV) is one of the leading cause of lymphoma in cats. Moreover, according to the Animal Cancer Foundation in 2015, around 6 million new cancer cases in dogs and cats are recorded, annually, in the U.S., of which one-third of all tumors in dogs are skin tumors, while around 20% are mast cell tumors.
  • However, adverse effects associated with chemotherapies, immunotherapies, and targeted therapies such as diarrhoea, anorexia, decreased appetite, lethargy, neutropenia, emesis, lameness, severe weight loss, and musculoskeletal disorder are major factors restraining the veterinary oncology market growth.

Key features of the study:

  • This report provides in-depth analysis of the global veterinary oncology market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 - 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
  • It profiles key players in the global veterinary oncology market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global veterinary oncology market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global veterinary oncology market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Veterinary Oncology Market, By Animal Type:
  • Companion Animal
    • Equine
    • Canine
    • Feline
  • Livestock Animal
  • Global Veterinary Oncology Market, By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
  • Global Veterinary Oncology Market, By Mode of Administration:
  • Oral
  • Intravenous
  • Global Veterinary Oncology Market, By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
  • Global Veterinary Oncology Market, By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Global Veterinary Oncology Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Middle East
    • By Country/Region:
  • GCC
  • Israel
  • Rest of Middle East
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Company Profiles
    • Zoetis Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Animal Type
    • Market Snippet, By Therapy Type
    • Market Snippet, By Mode of Administration
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Initiatives for Prevention and Control of Veterinary Oncology
  • Radiation Therapy
  • Market Trends
  • Product Recall
  • Epidemiology
  • Key Developments
  • Cancers in Cats
  • Cancers in Dogs
  • Chemotherapy Agents Commonly used in Veterinary Medicine
  • Regulatory Scenario
  • Veterinary Medicines: Patent Information
  • Veterinary Cancer: Awareness Campaign
  • Mergers and Acquisitions
  • PEST Analysis

4. Global Veterinary Oncology Market, By Animal Type, 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Companion Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Equine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Canine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Feline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Livestock Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

5. Global Veterinary Oncology Market, By Therapy Type 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Combination Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

6. Global Veterinary Oncology Market, By Mode of Administration , 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

7. Global Veterinary Oncology Market, By Application, 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Canine Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Osteosarcoma (OSA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Mast Cell Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Multiple Myeloma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

8. Global Veterinary Oncology Market, By Distribution Channel, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

9. Global Veterinary Oncology Market, By Region, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2019 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2019 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

10. Competitive Landscape

  • Company Profiles
    • Zoetis Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Elanco
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AB Science
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Boehringer Ingelheim International GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zenoaq
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • VetDC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Morphogenesis, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Karyopharm Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Regeneus Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AdvaVet, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Rhizen Pharmaceutical SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact